Form 8-K - Current report:
SEC Accession No. 0000200406-19-000071
Filing Date
2019-12-30
Accepted
2019-12-30 17:13:33
Documents
15
Period of Report
2019-12-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a20191230form8-k.htm   iXBRL 8-K 50821
2 EXHIBIT 99.1 a20191230exhibit991.htm EX-99.1 15488
  Complete submission text file 0000200406-19-000071.txt   277833

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20191230.xsd EX-101.SCH 5671
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jnj-20191230_cal.xml EX-101.CAL 597
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20191230_def.xml EX-101.DEF 16912
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20191230_lab.xml EX-101.LAB 38582
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20191230_pre.xml EX-101.PRE 19058
16 EXTRACTED XBRL INSTANCE DOCUMENT a20191230form8-k_htm.xml XML 11001
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1229
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 191317306
SIC: 2834 Pharmaceutical Preparations